Abstract

Purified bovine brain G-protein was used in a solution phase assay to identify membrane-associated proteins that influenced the activation of heterotrimeric G-proteins. Detergent-solubilized membrane extracts from the neuroblastoma-glioma cell hybrid NG108-15, but not the parent C6B4 glioma cell line, increased [35S]GTPgammaS binding to purified G-protein by approximately 460%. The G-protein activator was heat-sensitive, and the magnitude of its action was related to the amount of extract protein. The biophysical and biochemical properties of the G-protein activator were determined using DEAE ion exchange chromatography, gel filtration, and a lectin affinity matrix. In the presence of added GDP (1 microM), the enriched G-protein activator increased the initial rate of [35S]GTPgammaS binding to brain G-protein by up to 4-fold. In the absence of added GDP, the G-protein activator elicited an initial burst in [35S]GTPgammaS binding to brain G-protein within the first 30 s, after which the rate of nucleotide binding to G-protein was similar in the absence or presence of the G-protein activator. The stimulation of nucleotide binding to brain G-protein by the activator was also observed after resolution of Galpha from Gbetagamma. The G-protein activator was distinct from other proteins (neuromodulin, tubulin, and beta-amyloid precursor protein) that influence nucleotide binding to G-protein, indicating the existence of a novel signal accelerator.

Highlights

  • ¶ To whom correspondence should be addressed: Dept. of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC 29425

  • Effect of Membrane Extracts on [35S]GTP␥S Binding to Bovine Brain G-protein—A solution phase assay was developed to search for substances that influenced nucleotide binding to heterotrimeric G-protein

  • Membrane extracts were incubated with bovine brain G-protein in the presence of GDP, and aliquots were added to binding tubes containing [35S]GTP␥S to determine effects of extracts on nucleotide binding to G-protein

Read more

Summary

EXPERIMENTAL PROCEDURES

Tissue culture supplies were obtained from JRH Bioscience (Lenexa, KS). Acrylamide, bisacrylamide, and SDS were purchased from Bio-Rad. Nitrocellulose and polyvinylidene difluoride membranes were obtained from Schleicher & Schuell. Antisera recognizing Go and caveolin (common for caveolin-1, -2, and -3) were kindly provided by Dr Eva J. Neer (Harvard Medical School) [25] and Dr Michael P. Lisanti (Whitehead Institute for Biomedical Research) [23, 24], respectively. The monoclonal antibody to ␣ and ␤ tubulin were obtained from Amersham. Gel filtration molecular weight markers were purchased from Sigma and Boehringer Mannheim. Ecoscint A was purchased from National Diagnostics (Manville, NJ). Guanosine triphosphate, Thesit (polyoxyethylene-9-lauryl ether), monoclonal antibodies to neuromodulin (clone 91E12), and ␤-amyloid precursor protein (clone 22C11) were obtained from Boehringer Mannheim

The abbreviations and trivial names used are
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call